These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11788236)
21. Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. Leroy K; Brion JP J Chem Neuroanat; 1999 Jun; 16(4):279-93. PubMed ID: 10450875 [TBL] [Abstract][Full Text] [Related]
22. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Hoeflich KP; Luo J; Rubie EA; Tsao MS; Jin O; Woodgett JR Nature; 2000 Jul; 406(6791):86-90. PubMed ID: 10894547 [TBL] [Abstract][Full Text] [Related]
23. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251 [TBL] [Abstract][Full Text] [Related]
24. Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter. Lau KF; Miller CC; Anderton BH; Shaw PC Genomics; 1999 Sep; 60(2):121-8. PubMed ID: 10486203 [TBL] [Abstract][Full Text] [Related]
25. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082 [TBL] [Abstract][Full Text] [Related]
26. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Hardt SE; Sadoshima J Circ Res; 2002 May; 90(10):1055-63. PubMed ID: 12039794 [TBL] [Abstract][Full Text] [Related]
27. The role of glycogen synthase kinase-3beta in schizophrenia. Koros E; Dorner-Ciossek C Drug News Perspect; 2007 Sep; 20(7):437-45. PubMed ID: 17992266 [TBL] [Abstract][Full Text] [Related]
28. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. Pei JJ; Braak E; Braak H; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF J Neuropathol Exp Neurol; 1999 Sep; 58(9):1010-9. PubMed ID: 10499443 [TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571 [TBL] [Abstract][Full Text] [Related]
34. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152 [TBL] [Abstract][Full Text] [Related]
35. Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. Murai H; Okazaki M; Kikuchi A FEBS Lett; 1996 Aug; 392(2):153-60. PubMed ID: 8772194 [TBL] [Abstract][Full Text] [Related]
36. Wnt-1 dependent activation of the survival factor NF-kappaB in PC12 cells. Bournat JC; Brown AM; Soler AP J Neurosci Res; 2000 Jul; 61(1):21-32. PubMed ID: 10861796 [TBL] [Abstract][Full Text] [Related]
37. New steps in the Wnt/beta-catenin signal transduction pathway. Sakanaka C; Sun TQ; Williams LT Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939 [TBL] [Abstract][Full Text] [Related]